When Rachel Archer noticed a small pimple on her forehead, she thought nothing of it—having acne-prone skin, she was used to ...

When non-small cell lung cancer (NSCLC) spreads beyond the lungs, it often metastasizes to the bones. Estimates suggest 20 to 30 percent of people with NSCLC have bone metastases at the time of ...

Cancer is not a welcome diagnosis, but breakthroughs in genetic sequencing and immunotherapy are making some cancers easier ...

A 14-gene assay predicts chemotherapy benefit in early-stage non-small-cell lung cancer, improving 24-month disease-free ...

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

CHEST guideline updates support minimally invasive resection and targeted therapy to enhance survival in Stage I–II NSCLC.

Cambridge: AstraZeneca has received approval for Imfinzi (durvalumab) in the European Union (EU) for the treatment of adult ...

At just 52 years old, a woman has been diagnosed with Stage 4 lung cancer. A non-smoker who had worked full-time since age 22, she now faces a terminal illness while trying to support her husband and ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

The majority of patients with the most common advanced or metastatic cancers in the United States do not undergo ...

AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...

Gallbladder cancer, a rare malignancy affecting the organ storing bile, often presents without early symptoms, leading to ...